Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There's no bid, that shit volume doesn't support a bid,! It might as well be zero!
What's your point now?
And in case you think "no-bid" is just words...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174618590
Foxo is junk... 2, 1-10 rs and trading at a split-adjusted price of
0.00249!!!!!!!!!
https://stockanalysis.com/stocks/foxo/statistics/
Never left. How long has it been at no bid? That is a true measure of worthlessness.
Mr Stock Market, what are the implications and the interpretations one should familiarize themselves with under a no-bid condition?
When a stock is at "no bid," it means there are no current buy orders for that stock at any price. This situation has several implications for a long shareholder (someone who owns shares of the stock with the expectation that the price will rise):
Liquidity Issues: The lack of bids indicates a significant liquidity problem. The shareholder may find it extremely difficult to sell their shares because there are no buyers willing to purchase them at any price.
Potential Price Drop: The absence of bids usually suggests that the stock is highly undesirable at the moment. This can lead to a rapid decline in the stock's price if a sell order is placed, as the next available bid may be significantly lower than the last traded price.
Market Sentiment: The situation reflects very negative market sentiment towards the stock. Investors might be avoiding the stock due to perceived high risks, financial instability of the company, or unfavorable market conditions affecting the company’s sector.
Risk of Delisting: Stocks that consistently have no bids and trade at very low volumes are often at risk of being delisted from major stock exchanges. Delisting would further reduce the stock's liquidity and make it more difficult to trade.
Valuation Concerns: A no-bid status can signal severe underlying issues with the company's fundamentals, such as financial distress, impending bankruptcy, or other significant problems that erode investor confidence.
Mr Stock Market, you mention financial distress. I seem to recall that RNVA has a going concern issue in their last filing. Is this so?
Yes, Rennova Health, Inc. (RNVA) indicated a going concern issue in its latest financial filings. This term implies that there is substantial doubt about the company's ability to continue operating in the foreseeable future. This typically stems from financial instability, such as continuous losses, liquidity issues, or other significant operational challenges. The company has faced ongoing difficulties that raise concerns about its ability to meet obligations and sustain operations without significant restructuring or additional financing? (Rennova Health)?.
https://ir.rennovahealth.com/all-sec-filings
Thank you Mr Stock Market!
Hope all of you new and potential longs are well informed. This went kind of under the radar in the wake of the share exchange.
https://www.globenewswire.com/news-release/2024/06/14/2899204/0/en/FOXO-Technologies-Inc-Announces-Receipt-of-Notice-of-Non-Compliance-with-NYSE-Continued-Listing-Requirements-Completes-Steps-it-Believes-are-Required-to-Regain-Compliance.html
Also, horrible financial analytics. Not exactly sure how RNVA benefits from receiving shares in the exchange in a company so obviously circling the drain.
https://stockanalysis.com/stocks/foxo/statistics/
Trading suckS 161.00 average dollar trade size.
$718702
Trades 4439
AVG 161.9062852
Yes yes yes...and because Foxo has done only two reverse splits, both 1 for 10, whereas RNever has done 9 and this little pre-release of the 10k has failed to move the stock, it really does seem that RNVA is all played out...
The Company is announcing select preliminary results for the year ended December 31, 2023 for RCHI and Myrtle. Based on its preliminary unaudited estimates and
information available as of the date hereof, the Company expects net revenue of approximately $18.7 million and net income of approximately $5.2 million for RCHI and
Myrtle for the year ended December 31, 2023. The combined net revenues and net income for RCHI and Myrtle do not reflect the consolidated net revenues and net income of
the Company as the financial results of other Company entities are not included. Final results for the year ended December 31, 2023 will be reported in the Company’s Annual
Report on Form 10-K.
On the other hand, FOXO is hardly an NYSE behemoth currently on the clock for paying its listing fees so there is that.
https://www.otcmarkets.com/filing/html?id=17622678&guid=baQ-kWpmiByQh3h
Funny how this unflattering bit of news failed to garner any attention as it was overshadowed by a stock swap with more uncertainties than the Heisenberg Principle.
So says you. I am going to listen to the market in the absence of anything from RNVA. The market hasn't reacted well to this supposed corporate jargon: "rapid expansion of its core business."
2%? Yeah, that sounds like a great deal. That's at least what can be determined with the press release. Any more than that would require something coming out of RNVA. And that hasn't been much in more than a few months. I am going to go with what was stated from FOXO, not speculations from a message board.
The fact that Rennova Health (RNVA) itself has not issued any public statement or press release regarding this major proposed deal to essentially sell off its core healthcare operating subsidiaries to FOXO Technologies is very telling.
When a public company is involved in a transformative transaction like this, where it is divesting virtually all of its operating businesses, you would expect them to put out an official communication explaining:
1 The strategic rationale and benefits of the deal
2 What will happen to remaining assets/subsidiaries
3 How proceeds will be utilized
4 The future plans and path forward for the company post-transaction
The fact that Rennova has remained silent and let FOXO be the only party announcing the deal details suggests this may indeed be a situating of winding up and shutting down Rennova's operations.
Their lack of transparency and communication with their own investors raises suspicions that Rennova is purposely remaining quiet as it essentially sells off all substantive operations and assets to FOXO, potentially to facilitate a shut down or naked corporate shell remaining.
This opaque approach is highly concerning from a corporate governance perspective for any remaining Rennova shareholders. They deserve full transparency on whether this is truly an ongoing concern situation or just a precursor to winding up the company entirely.
The silence is deafening from Rennova's end and certainly bolsters the hypothesis that this is more of a winding up or liquidation event than a normal asset sale between two operating businesses. Investors should be very wary until Rennova addresses this clearly.
Trd4profit raises some troubling concerns for RNVA shareholders. This additional information sheds more light on what appears to be a concerning situation regarding Rennova Health after this proposed deal with FOXO Technologies.
FOXO will acquire more than 98% of Myrtle Recovery Centers' issued and outstanding shares for $500,000 and all of the issued and outstanding shares of Rennova Community Health, which owns Scott County Community Hospital, for $20 million of convertible preferred stock, according to a late Thursday filing.
The key details are:
FOXO is acquiring over 98% of Myrtle Recovery Centers and 100% of Rennova Community Health (which owns Scott County Community Hospital) and ALL=(100%) issued and outstanding shares of RNVA.
These two subsidiaries generated $18.7 million in revenue and $5.2 million in net income for 2023 based on unaudited financials provided
Given that FOXO is essentially acquiring Rennova's entire healthcare operations business through these two main subsidiaries, it raises the question - what is actually left under the Rennova Health corporate entity after this deal?
It seems like Rennova could be left as an empty shell company with few/no operating assets or subsidiaries remaining if this transaction goes through as described.
This raises additional red flags about Rennova's motivations here. Are they essentially stripping out their core healthcare assets, keeping the proceeds, and leaving an empty public vehicle behind? It has shades of a potentially concerning corporate restructuring.
From FOXO's perspective, they better have done extensive due diligence on what exact assets, liabilities and legal entities they are acquiring to avoid potential landmines.
Overall, this raises more questions about the future of Rennova as a public company and whether there is any substantive operating business that will remain after cashing out on this deal with FOXO. Investors in both companies should be demanding much more transparency.
Equally troubling is the complete and total absence of any communication coming out of RNVA.
My assessment: This is not a positive for RNVA and the market seems to agree at least in the case of RNVA.
The U.S. has 9,850 centi-millionaires—those worth $100 million or more or 0.0033%. We are blessed to have someone like that in our midst. Truly rarified air.
I am too creaky to genuflect but if I could...
Mere dimes to the 100 million-dollar man, right? Surely, someone who purportedly cleared 14 million on TSLA options could take that out and your cash position wouldn't even know it.
Come on, show the people you have made that claim to that you aren't just another message board bullshitter.
You don't find that if this case might be the reason why RNVA can't find the time to file its delinquent annual filing gets relegated to the Expert Market, a justification for a bearish outlook?
Wow!
This should be stickied. Another justification for not buying or holding this stock. "Sell-side" or "Avoid" thesis, if ever there was one. And don't even get me started on the ridiculous number of reverse splits.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173234252
Have you picked up any SMCI, NVDA, NXPI or SWKS?
FWFIW, I can be anywhere I choose, and no stuck is going to tell me different.
So was I. The fees you mentioned were 18% of today's $volume. Sad, really that you are in a stock that can trade at such a pathetic traded value of equity.
So, in other words, almost 18% of RNVA's dollar volume of 87.00. Wow! And yet, the little campfire is a roaring blaze at the top of this page.
Yes, under certain regulations, employees of a private equity firm may need to file as a group with their employer. If they collectively acquire over 5% of a company’s shares, they might be considered a "group" and must file a Schedule 13D with the SEC, disclosing their combined ownership and intentions. Private equity firms often have policies to ensure compliance with these rules, requiring employees to disclose their holdings to facilitate proper filings. Recent updates to trading rules may also impact these requirements.
Now, how this might relate to this dead junk, you got me there.
This worthless junk was 6 bux a month ago. lOL
NVDL is not another company. It is a single-stock leveraged ETF that tracks NVDA Daily Long performance 2x.
https://graniteshares.com/institutional/us/en-us/etfs/nvdl/
This instrument is for sophisticated investors as has these basic performance and objectives and certain risks that are different buy/hold strategies of owning NVDA.
For example, if NVDA stock price increases by 1% on a given day, NVDL aims to increase by approximately 2%. Conversely, if NVDA decreases by 1%, NVDL would aim to decrease by about 2%. This leverage is reset daily, which can lead to different returns over longer periods due to compounding effects. It is a cash-settled instrument at the end of each day.
Cash-settled vs. Physical delivery: ETFs like NVDL are typically cash-settled, meaning investors don't take physical delivery of the underlying asset (in this case, NVDA shares). Instead, gains or losses are settled in cash based on the fund's performance.
Tracking performance: NVDL seeks to provide 2x daily leveraged returns of NVDA. This means it resets its leverage daily. Due to this daily reset and the effects of compounding, the performance of NVDL over periods longer than one day (like a week, month, or year) may not exactly match 2x the return of NVDA over the same period.
For example:
If NVDA goes up 5% in a week, NVDL might not return exactly 10% (2x5%).
If NVDA gains 20% in a month, NVDL might return more or less than 40%.
Over a year, the divergence can be even more pronounced.
This divergence occurs because of the compounding of daily returns, which can amplify gains in trending markets but also amplify losses in volatile or sideways markets. It's a common feature of leveraged ETFs and is often referred to as "volatility decay" or "beta slippage."
If you plan to trade this ETF should typically be one day. And I would highly recommend you also trade the NVD as a hedge.
https://graniteshares.com/institutional/us/en-us/etfs/nvd/
Vermin,
I RAN SBNY BANK FROM .006 to $$3.25
For 5,700 x my money . Sold too soon as it hit &3.40 darn
Do you realize $10,000 @.006 is now 34 million dollars
And it was a sub zero penny stock !!!!!
Actually could have got in the trips
Let me guess, you were all of the volume on those .006 days. LOL
Date Open High Low Close Adj Close Volume dollar voll No Trades Average $Trade
10/20/2023 0.006 0.006 0.005 0.005 0.005 39632 198 4 $50
10/23/2023 0.006 0.006 0.002 0.0022 0.0022 20357 45 4 $11
10/26/2023 0.006 0.0071 0.006 0.0071 0.0071 12445 88 10 $9
10/30/2023 0.006 0.006 0.006 0.006 0.006 6147 37 11 $3
11/2/2023 0.006 0.02 0.006 0.016 0.016 52949 847 22 $39
12/4/2023 0.006 0.08 0.006 0.08 0.08 67961 5,437 40 $136
12/7/2023 0.006 0.08 0.006 0.08 0.08 157637 12,611 42 $300
4/16/2024 3.2 3.25 2.8 3.15 3.15 149958 472,368 1,350 $350
5/13/2024 3.2 3.5 3.2 3.35 3.35 280473 939,585 12,528 $75
Extraordinary. What strategy did you use? What month contract and what did you pay? All questions you can answer that I can check for sanity. Chiefly, because I think you're FOS!
VARMY, what the HELL are you doing here? You mean to tell me you can take a million or so from your pockets, where a million is like a few dimes to you, and make some money on a real stock while you wait for this diluted pig to yield a G?
https://stocktwits.com/Victhestick/message/575600208
Off Topic but very interesting.
https://finance.yahoo.com/news/traders-scooped-warren-buffett-berkshire-105754520.html
T-1 ROOOAAAARRRRR!!!!!!!!!!!!!!!!!!!!!!!!!
https://stocktwits.com/Victhestick/message/574451619
Goon, see how easy it is to provide proof? Check out my post about my new entry into NVDA.
Sadly, his claim is one of those instances that requires extraordinary proof.
You too! Had a good week and now have become a proud owner of NDVA that is set to split 10 for 1 on June 10th.
https://stocktwits.com/Victhestick/message/574260458
Little bird told me SMCI is preparing to do the same 10 for 1.
Jensen Huang on Blackwell rollout.
https://finance.yahoo.com/news/nvidias-stock-split-isnt-something-for-investors-to-ignore-morning-brief-100008746.html
10 Year T Bill was up .53, initial claims were down, and Fed minutes show no signs of deviating from higher for longer. Here is the summary of the FOMC minutes I prepared for my finance team. Kind of all came to a head today.
https://www.federalreserve.gov/monetarypolicy/fomcminutes20240501.htm
Here are the key points from the FOMC minutes:
The Fed decided to keep the federal funds rate unchanged in the target range of 5.25-5.5%.
Inflation had eased over the past year but remained elevated, with a lack of further progress in recent months toward the 2% goal.
Economic activity continued to expand at a solid pace, with strong job gains and low unemployment.
The Fed judged the risks to achieving its employment and inflation goals had moved toward better balance over the past year, but the outlook remained uncertain with inflation risks still elevated.
The Fed decided to begin slowing the pace of reducing its securities holdings in June, lowering the monthly Treasury redemption cap from $60B to $25B and reinvesting excess agency MBS payments into Treasuries.
Most participants saw the need to keep policy restrictive until there was greater confidence inflation was moving sustainably back to 2%, though some were open to further tightening if inflation risks materialized.
There was uncertainty about the degree of restrictiveness of current policy given potential changes in the neutral rate and output potential.
The overall sentiment among Fed officials seemed to be one of cautious patience. While noting some progress on inflation, they remained highly attentive to upside risks and lacked confidence yet that inflation was on a sustained path back to 2%. Hence, most felt it appropriate to maintain a restrictive policy stance until clearer evidence of returning to the inflation target emerged.
Well, I am in. Buy/write out to Dec 26 1300 strike.
https://stocktwits.com/Victhestick/message/574065492
Reverse split-adjusted price .00044. 1.07/(3*80) Nice! No analysts coverage and there is a secular bear market for the EV space. Why is anybody long here? It looks like another RS is in the offing once this thing starts to run a sub-1.00 handle.
goldslacker2023 Please alert the FBI, SEC, and the World Police to this press release. I will be waiting to hear from all of them.
Emergency Follow-Up: GNCP Shareholders Overwhelm Blood Banks in Pursuit of "Gullibleinium"
[DATELINE, USA, May 21, 2024] – In a bizarre turn of events, blood banks across the nation are reporting unprecedented chaos as hundreds of GNCP shareholders flood their facilities, seeking to extract what they believe to be a newfound treasure: "Gullibleinium."
Desperate shareholders, facing financial hardship after GNCP's transition to the expert market, have resorted to selling their blood as a means to make ends meet. However, upon learning about the purported value of their blood, they have descended upon blood banks en masse, overwhelming staff and resources.
Reports from multiple locations depict scenes of confusion and frustration as shareholders demand immediate extraction of their "Gullibleinium." Many claim to have invested their life savings in GNCP, only to find themselves unable to trade their shares, leading them to believe that their blood might hold the key to financial salvation.
"We've never seen anything like this," remarked Dr. Emily Rodriguez, a hematologist at a major blood bank in New York City. "People are convinced that their blood contains some sort of valuable element related to their GNCP investments. It's causing a significant strain on our operations."
Similar incidents have been reported from coast to coast, with blood bank staff struggling to manage the influx of shareholders demanding blood extractions. Some shareholders have even resorted to desperate measures, attempting to perform self-extractions or demanding to be seen ahead of regular donors.
"We urge shareholders to remain calm and rational," pleaded Dr. Michael Chang, Chief Medical Officer of the American Association of Blood Banks. "While blood donation is a noble act, it should never be undertaken as a means of financial gain. Our primary concern is the health and safety of both donors and recipients."
Authorities are urging blood banks to implement additional security measures to manage the situation and ensure the safety of both staff and shareholders. Meanwhile, GNCP executives have yet to comment on the unfolding crisis, leaving many shareholders feeling abandoned and disillusioned.
Well, at least more so than they already are as a result of the failure of GNCP as an investment.
As the frenzy continues to escalate, experts warn of potential health risks associated with excessive blood donation and remind shareholders to seek financial advice from qualified professionals. The pursuit of "Gullibleinium" may prove to be a cautionary tale of the perils of blind investment and the consequences of unchecked speculation.
Are you on food stamps? Average trade size 194.00. Piker trash. NVDA-heavy options traders wouldn't waste their time. Nice try though trying to get them to bail you out of this mess.
You're welcome!
FOR IMMEDIATE RELEASE
GNCP Capital Unveils Groundbreaking Discovery of Gullibleinium, a Rare Earth Mineral Found in Shareholders' Bloodstreams
Durban, South Africa - GNCP Capital, the pioneering force in the untradable expert market, is thrilled to announce a monumental breakthrough in the world of finance: the discovery of Gullibleinium, a rare earth mineral found exclusively in the bloodstreams of its most dedicated shareholders.
Following extensive research and countless blood tests, GNCP Capital's team of esteemed experts stumbled upon this extraordinary find, hidden in the depths of shareholder veins. Gullibleinium, named for its affinity with those with an unwavering belief in the company's potential, promises to revolutionize the way we perceive investment opportunities.
"This discovery marks a turning point not only for GNCP Capital but for the entire financial sector," remarked Dr. Ivan Ivestment, Chief Scientist at GNCP Capital. "Gullibleinium's unique properties offer a glimpse into the untapped potential within our shareholder base. It's truly remarkable."
Initial studies suggest that Gullibleinium possesses unparalleled qualities, including the ability to enhance optimism levels to unprecedented heights and to blind investors to pesky details like market trends or financial analysis.
"We've always believed in the loyalty and dedication of our shareholders, and now we have scientific proof of their unwavering commitment," stated CEO Ron Lowlifestein Greed. "With Gullibleinium on our side, the sky's the limit for GNCP Capital."
As news of the discovery spreads, GNCP Capital anticipates a surge in investor enthusiasm, with shareholders clamoring to get a piece of the action.
"Finally, a mineral that truly reflects the spirit of our investor community," exclaimed one shareholder upon hearing the news. "I can't wait to see how this impacts our stock price!"
In light of this groundbreaking revelation, GNCP Capital is exploring various applications for Gullibleinium, including potential partnerships with other companies in need of a boost in investor morale.
For more information on GNCP Capital and the remarkable discovery of Gullibleinium, please visit our website or contact our investor relations team.
About GNCP Capital:
GNCP Capital is a trailblazer in the untradable expert market, committed to pushing the boundaries of what's possible in finance. With a dedicated team of visionaries and a loyal shareholder base, GNCP Capital is poised for greatness.
Contact:
Investor Relations
GNCP Capital
Phone: 555-555-5555
Email: invest@gncpcapital.com
Website: www.gncpcapital.com
Parody is not a crime. Not recognizing it is criminal stupidity. I guess that's why you find yourself stuck in this turd.
But by all means, call the cops.
Tool!
What if I construct another gem of a realistic-sounding press release and you alert them of it and then they'll reply that you should ignore it? That will at least be something confirming they're not all dead. LOLO
If you like that, then you'll love this.
https://stocktwits.com/symbol/SMCI
In at 488.00 not selling anytime soon if ever! You ever want to trade a real stock, look me up.
During the Spanish Inquisition, Tomas De Torquemada "deployabled" iron thumbscrews, head squeezers, stretching racks, and interrogation chairs with spikes, while piped choral music was played in the background, and fresh flowers next to some of the most disturbing exhibits for the consumption of would be heretics and potential apostates, in events that felt like a funeral. He acted as the ruthlessly cruel first Grand Inquisitor of the Spanish Inquisition and was responsible for directing its early activities against Jews and Muslims in Spain, and in fashioning its methods, including the use of torture and burnings. Fun stuff that I'm sure you wish could happen to Gensler and Soros, right? You and the Torq will probably have a lot to share someday once you shuffle off your mortal coil. My inclination is that you will share the same zip code.
Anti-semitic tropes much? Deplorable. You share the same affliction of the "Grand" Torq and Hitler. Must make you so proud.
Blame yourself for your stock-picking blunders. You might actually get better at the game someday if you were to take ownership of your failures. That's what successful traders do.
S&P 500, Nasdaq rise to all-time highs
https://www.cnbc.com/2024/05/14/stock-market-today-live-updates.html
Damn you Gensler, Soros, Biden {Insert Right-Wing Boogieman here}!!!!!
https://www.gurufocus.com/guru/leon%2Bcooperman/stock-picks?view=table
Pay attention to this man.
https://finance.yahoo.com/video/gamestop-stock-pops-roaring-kitty-141222957.html
Look at the Pin Risk on the Call at 25, 30 and 34 for the Friday expiry. Someone knew this resurfacing was going to happen forcing the dealer to delta hedge this move. This is what a gamma squeeze looks like.
Open interest May 17 EXP.
25 26,620 contracts
30 41,392 contracts
34 16,660 contracts
While the stock has been halted several times today, the options are burning up. By the way, these options were in the 40 cents a contract range on Friday close. Now 8, 6.50, and 6.02, for the 25,30 and 34 calls. NIce multibagger for those who front ran the return of Roaring Kitty.
Gamma squeeze is relatively rare compared to short squeeze. The most famous examples of the gamma squeeze are the rise in the value of GameStop and AMC Entertainment stocks.
The same players led by Roaring Kitty are at it again. This could go back up to 100.00 once the options chains has prints above 34.00 out in time.